Journal News

Harnessing a natural plant insecticide for commercial use

Elisabeth Adkins Marnik
June 25, 2024

Many plants produce molecules or peptides that help them combat destructive insects. These natural insecticides hold a lot of promise for improving how we can protect crops around the world from pests without harming the environment 

Developing plant insecticides into eco-friendly products is one area of interest in David Craik’s laboratory, which is part of the Institute for Molecular Bioscience at the University of Queensland, Brisbane, Queensland, Australia.

Craik’s lab identified a group of cyclotides in a prior study and found that they have natural insecticidal properties. Cyclotides are unique; unlike typical peptides that form linear chains of amino acids, cyclotides link together end to end to form circular peptides. These cyclopeptides can interact with specific phospholipids that form cell membranes. This can happen within the insect’s gut and cause cell swelling or lysis that results in death or growth restriction of the insect. The Craik lab has become interested in studying the applications of these cyclotides, particularly as potential pesticides.

In their recent study, conducted in collaboration with Syngenta Crop Protection AG, an international agriculture technology company, and published in the Journal of Biological Chemistry, Craik’s lab focused on a specific cyclotide known as kalata B1. For an insecticide to have broad use, a business must be able to manufacture it efficiently and cost-effectively. It must also remain stable in a variety of environmental conditions where factors such as temperature and pH may differ considerably.

To address these issues, the Craik lab mutated specific amino acids within the cyclotide to determine their impact on the molecule's stability under varying conditions. This was achieved through a technique called a lysine scan, where each amino acid within the cyclotide was systematically replaced with lysine. The researchers then evaluated whether the change enhanced the stability of the cyclopeptide.

This work enabled the lab to create a more stable cyclopeptide capable of targeting insect cells from the fall armyworm, a major pest worldwide. They also confirmed that they could manufacture this cyclopeptide efficiently and safely.

“We can actually use a natural recombinant process to produce these proteins,” Craik said. “Some types of peptide synthesis can be quite an environmentally unfriendly process in terms of the amount of waste materials produced. But if you can produce peptides, and then cyclize them using enzymes rather than chemicals, you have a much greater production pathway.”

As of now, the only other cyclotide insecticide on the market is one known as Sero-x. Approved for use in Australia, it is applied to cotton plants and certain vegetable crops.

The next step for the Craik lab is to feed the cyclotide insecticide to fall armyworms and determine if it is effective in killing them. If these trials prove successful, another cyclotide insecticide may soon be available for use.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Elisabeth Adkins Marnik

Elisabeth Adkins Marnik is the science education and outreach coordinator at the MDI Biological Laboratory in Bar Harbor, Maine, where she is spearheading the development of new programming.  This work is driven by her passion for making science accessible to students and the public. She is an ASBMB Today volunteer contributor as well as a contributing writer to Those Nerdy Girls and The Global Autoimmune Institute. Follow her on Instagram @sciencewhizliz.
 

Related articles

From the journals: JBC
Ken Farabaugh
From the Journals: JBC
Ken Farabaugh
From the journals: JBC
Ken Farabaugh
No oxygen? No problem
Marissa Locke Rottinghaus
From the journals: JBC
Ken Farabaugh

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Adults grow new brain cells
News

Adults grow new brain cells

Jan. 11, 2025

How does the rare birth of these new neurons contribute to cognitive function?

From the journals: JBC
Journal News

From the journals: JBC

Jan. 9, 2025

Histone demethylase inhibited by own sequence. MicroRNA reduces cell cycle–related apoptosis. Multipurpose antibiotic takes on staph infections. Read about recent JBC papers on these topics.

Tiny laboratories that fit in your hand can rapidly identify pathogens using electricity
News

Tiny laboratories that fit in your hand can rapidly identify pathogens using electricity

Jan. 5, 2025

Pathogens have distinct electrical charges, shapes and sizes. Measuring how quickly they move through an electric field can help researchers separate different species in a sample.

Toxoplasma gondii parasite uses unconventional method to make proteins for evasion of drug treatment
News

Toxoplasma gondii parasite uses unconventional method to make proteins for evasion of drug treatment

Jan. 4, 2025

This recent study by a team from Bill Sullivan’s lab at the Indiana University School of Medicine was named a Journal of Biological Chemistry Editor’s Pick.

Of genes, chromosomes and oratorios
Profile

Of genes, chromosomes and oratorios

Jan. 1, 2025

Jenny Graves has spent her life mapping genes and comparing genomes. Now she’s created a musical opus about evolution of life on this planet — bringing the same drive and experimentalism she brought to the study of marsupial chromosomes.

Ubiquitination by TRIM13: An ingredient contributing to diet-induced atherosclerosis
Journal News

Ubiquitination by TRIM13: An ingredient contributing to diet-induced atherosclerosis

Dec. 31, 2024

Researchers help unravel the molecular mechanism behind plaque formation in cardiovascular disease.